The differential expression of EZH2 in stage IA, IB and IC endometrial cancer was not significantly different and indicated that it is more important in the discrimination of early-stage endometrial cancer than advanced endometrial cancer (stage II, III and IV). Here, EZH2 is linked to endometrial cancer.